氧化还原酶DHTKD1基因突变致病机制及小鼠模型研究进展

doi:10.3969/j.issn.1674-5817.2018.06.013

实验动物与比较医学 ›› 2018, Vol. 38 ›› Issue (6): 468-472.DOI: 10.3969/j.issn.1674-5817.2018.06.013

• 综述 • 上一篇

氧化还原酶DHTKD1基因突变致病机制及小鼠模型研究进展

沈艳, 徐汪洋, 朱后保

上海交通大学医学院附属瑞金医院实验医学研究中心,上海 200025

收稿日期:2018-06-06 出版日期:2018-12-25 发布日期:2021-03-01
作者简介:沈艳(1977-),女,预防兽医学硕士,高级兽医师,从事实验动物兽医工作。E-mail:35840478@qq.com
基金资助:
国家自然科学基金(81201365和81502048)

Research Progress on Pathogenesis of Hereditary Diseases Caused by Mutations of Oxidoreductase DHTKD1 and Related Mouse Models

SHEN Yan, XU Wang-yang, ZHU Hou-bao

Research Center for Experimental Medicine of Rui-Jin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China

Received:2018-06-06 Online:2018-12-25 Published:2021-03-01

摘要/Abstract

摘要： 氧化还原酶,脱氢酶E1和转酮酶结构域1(DHTKD1)通过催化2-酮己二酸氧化脱氢生成戊二酰辅酶A,终产物乙酰辅酶A进入三羧酸循环,产生三磷酸腺苷(ATP)为细胞机体提供能量。迄今为止,研究显示,DHTKD1基因多个位点的突变与线粒体功能障碍有关,最终导致人类遗传疾病的发生。本文重点阐述了DHTKD1基因突变与人类遗传病的相关性及其相应的机制,并对已有的2种基因敲除小鼠模型进行了比较探讨。

关键词: 脱氢酶E1和转酮酶结构域1(DHTKD1)基因, 基因突变, 遗传病, 线粒体, 小鼠模型

Abstract: As an oxidoreductase, dehydrogenase E1 and transketolase domain-containing 1(DHTKD1)catalyzes the oxidation dehydrogenation of 2-ketoadipic acid to produce glutaryl-CoA. Then the final product, acetyl-CoA enters the tricarboxylic acid cycle, finally producing adenosine-triphosphate (ATP) to provide energy for the cell and organism. So far, researchers have found that mutations in multiple loci of DHTKD1 gene are associated with mitochondrial dysfunction, leading to genetic diseases in human. This article focuses on the correlation between DHTKD1 gene mutation and human genetic diseases, and discussion about the corresponding mechanism. Furthermore, we dialectically discuss two available knockout mouse models.

Key words: Dehydrogenase E1 and transketolase domain-containing 1(DHTKD1) gene, Gene mutation, Genetic disease, Mitochondrion, Mouse model

中图分类号:

Q95-33

沈艳, 徐汪洋, 朱后保. 氧化还原酶DHTKD1基因突变致病机制及小鼠模型研究进展[J]. 实验动物与比较医学, 2018, 38(6): 468-472.

SHEN Yan, XU Wang-yang, ZHU Hou-bao. Research Progress on Pathogenesis of Hereditary Diseases Caused by Mutations of Oxidoreductase DHTKD1 and Related Mouse Models[J]. Laboratory Animal and Comparative Medicine, 2018, 38(6): 468-472.

参考文献

[1] Danhauser K,Sauer SW,Haack TB,et al.DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria[J].Am J Hum Genet,2012,91(6):1082-1087.
[2] Xu WY,Gu MM,Sun LH,et al.A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree[J].Am J Hum Genet,2012,91(6):1088-1094.
[3] Hagen J,te Brinke H,Wanders RJ,et al.Genetic basis of alpha-aminoadipic and alpha-ketoadipic aciduria[J].J Inherit Metab Dis,2015,38(5):873-879.
[4] Stiles AR,Venturoni L,Mucci G,et al.New cases of DHTKD1 mutations in patients with 2-ketoadipic aciduria[J].JIMD Rep,2016,25:15-19.
[5] Sherrill JD,Kc K,Wang X,et al.Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis[J].JCI Insight,2018,3(8):pii:99922.
[6] Bunik VI,Degtyarev D.Structure-function relationships in the 2-oxo acid dehydrogenase family:substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like proteins[J].Proteins,2008,71(2):874-890.
[7] Nagase T,Kikuno R,Nakayama M,et al.Prediction of the coding sequences of unidentified human genes.XVIII.The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro[J].DNA Res,2000,7(4):273-281.
[8] Xu W,Zhu H,Gu M,et al.DHTKD1 is essential for mitochondrial biogenesis and function maintenance[J].FEBS letters,2013,587(21):3587-3592.
[9] Goncalves RL,Bunik VI,Brand MD.Production of superoxide/hydrogen peroxide by the mitochondrial 2-oxoadipate dehydrogenase complex[J].Free Radic Biol Med,2016,91:247-255.
[10] Xu WY,Zhu H,Shen Y,et al.DHTKD1 deficiency causes Charcot-Marie-Tooth disease in mice[J].Mol Cell Biol,2018,38(13):pii:e00085-18.
[11] Saporta AS,Sottile SL,Miller LJ,et al.Charcot-Marie-Tooth disease subtypes and genetic testing strategies[J].Ann Neurol,69(1):22-33.
[12] Pareyson D,Saveri P,Pisciotta C.New developments in Charcot-Marie-Tooth neuropathy and related diseases[J].Curr Opin Neurol,2017,30(5):471-480.
[13] Duran M,Beemer FA,Wadman SK,et al.A patient with alpha-ketoadipic and alpha-aminoadipic aciduria[J].J Inherit Metab Dis,1984,7(2):61.
[14] Przyrembel H,Bachmann D,Lombeck I,et al.Alpha-ketoadipic aciduria,a new inborn error of lysine metabolism;biochemical studies[J].Clin Chim Acta,1975,58(3):257-269.
[15] Liacouras CA,Furuta GT,Hirano I,et al.Eosinophilic esophagitis:updated consensus recommendations for children and adults[J].J Allergy Clin Immunol,2011,128(1):3-20.
[16] O'Shea KM,Aceves SS,Dellon ES,et al.Pathophysiology of Eosinophilic Esophagitis[J].Gastroenterology,2018,154(2):333-345.
[17] Sherrill JD,Rothenberg ME.Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies[J].J Allergy Clin Immunol,2011,128(1):23-32.
[18] Kottyan LC,Rothenberg ME.Genetics of eosinophilic esophagitis[J].Mucosal Immunol,2017,10(3):580-588.
[19] Kottyan LC,Davis BP,Sherrill JD,et al.Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease[J].Nat Genet,2014,46(8):895-900.
[20] Rothenberg ME,Spergel JM,Sherrill JD,et al.Common variants at 5q22 associate with pediatric eosinophilic esophagitis[J].Nat Genet,2010,42(4):289-291.
[21] Blanchard C,Stucke EM,Burwinkel K,et al.Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis[J].J Immunol,2010,184(7):4033-4041.
[22] Sherrill JD,Kiran KC,Blanchard C,et al.Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing[J].Genes Immun,2014,15(6):361-369.
[23] Qiu LQ,Cresswell P,Chin KC.Viperin is required for optimal Th2 responses and T-cell receptor-mediated activation of NF-kappaB and AP-1[J].Blood,2009,113(15):3520-3529.
[24] Biagosch C,Ediga RD,Hensler SV,et al.Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism[J].Biochim Biophys Acta,2017,1863(9):2220-2228.
[25] 郭文婷.Dhtkd1基因点突变敲入小鼠模型的建立与表型初步分析[D].上海:上海交通大学,2013.
[26] 栾春杰,Dhtkdl无义突变敲入小鼠模型的建立和表型分析和遗传性蛋白C缺乏症致病机制的研究[D].上海:上海交通大学,2014.

氧化还原酶DHTKD1基因突变致病机制及小鼠模型研究进展

Research Progress on Pathogenesis of Hereditary Diseases Caused by Mutations of Oxidoreductase DHTKD1 and Related Mouse Models

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李晗, 张笑瑞, 张成芳. 间歇禁食法在改善奥氮平诱导小鼠代谢紊乱中的机制研究[J]. 实验动物与比较医学, 2023, 43(1): 3-10.
[2]	于士颜. 小鼠模型在消化道黏膜免疫及感染性疾病研究中的应用进展[J]. 实验动物与比较医学, 2022, 42(1): 3-10.
[3]	姚玎, 周晶, 严国锋, 王会阳, 汪雅荻, 马政文. 盐敏感性高血压小鼠模型的建立[J]. 实验动物与比较医学, 2020, 40(4): 314-.
[4]	柴文君, 孙磊, 刘晓丽, 潘洪玉, 郭天安, 徐烨, 闫明霞. 超声引导下左心室内注射人肺癌细胞建立骨转移小鼠模型[J]. 实验动物与比较医学, 2020, 40(3): 183-.
[5]	蒋红利, 马红叶, 薛瑾虹, 孙凌霜, 陈蕾. 绒毛蛋白1在单侧肾切除Habu肾炎小鼠模型中的作用[J]. 实验动物与比较医学, 2020, 40(1): 1-8.
[6]	李英娘, 戴玮, 盛健. 斑马鱼甲状腺肿大病例分析[J]. 实验动物与比较医学, 2019, 39(6): 462-466.
[7]	李慧. Foxp2小鼠模型中发育性言语障碍的分子遗传学研究[J]. 实验动物与比较医学, 2019, 39(4): 331-336.
[8]	何一旻, 顾鸣敏. Myh13敲除小鼠表型的初步分析[J]. 实验动物与比较医学, 2019, 39(3): 193-200.
[9]	沈艳, 王韵, 张汝, 阮铮, 毛建华. 两种小鼠肺癌模型的构建及Micro PET-CT观察[J]. 实验动物与比较医学, 2019, 39(1): 39-45.
[10]	纪莲, 马铁, 狄正鸿, 刘冬妍. 小鼠特应性皮炎建模方法的改进[J]. 实验动物与比较医学, 2018, 38(4): 267-271.
[11]	濮祥强, 王祥, 钱光辉, 马锦, 丁粤粤, 吕海涛. 小鼠免疫性冠状动脉炎内皮细胞线粒体的动态变化[J]. 实验动物与比较医学, 2018, 38(3): 169-175.
[12]	常凯, 王裕, 庞文彪, 高继萍, 陈朝阳, 宋国华. 硒对氟致大鼠肾小管上皮细胞线粒体膜电位改变的拮抗作用[J]. 实验动物与比较医学, 2017, 37(3): 179-184.
[13]	顾晓雯, 孙瑞林, 费俭. Afp-cre-lacZ转基因小鼠的构建[J]. 实验动物与比较医学, 2017, 37(2): 89-93.
[14]	宋莹, 郭雅娟, 黄铭倩, 梁金强, 黄芝瑛. 不同因素对环磷酰胺诱导的免疫抑制小鼠模型效果的影响[J]. 实验动物与比较医学, 2017, 37(1): 36-39.
[15]	李媛, 张梅英. 自噬与帕金森疾病及相关性模型的研究进展[J]. 实验动物与比较医学, 2015, 35(4): 335-340.